115 related articles for article (PubMed ID: 32366408)
1. Establishment of a Liver Transplant Patient-derived Tumor Xenograft (PDX) Model Using Cryopreserved Pancreatic Ductal Adenocarcinoma.
Tanaka R; Kageyama K; Kimura K; Eguchi S; Tauchi J; Shinkawa H; Ohira GO; Yamazoe S; Yamamoto A; Tanaka S; Amano R; Tanaka H; Yashiro M; Kubo S; Ohira M
Anticancer Res; 2020 May; 40(5):2637-2644. PubMed ID: 32366408
[TBL] [Abstract][Full Text] [Related]
2. Tumor engraftment in patient-derived xenografts of pancreatic ductal adenocarcinoma is associated with adverse clinicopathological features and poor survival.
Pergolini I; Morales-Oyarvide V; Mino-Kenudson M; Honselmann KC; Rosenbaum MW; Nahar S; Kem M; Ferrone CR; Lillemoe KD; Bardeesy N; Ryan DP; Thayer SP; Warshaw AL; Fernández-Del Castillo C; Liss AS
PLoS One; 2017; 12(8):e0182855. PubMed ID: 28854237
[TBL] [Abstract][Full Text] [Related]
3. Surgical and Oncological Factors Affecting the Successful Engraftment of Patient-derived Xenografts in Pancreatic Ductal Adenocarcinoma.
Jun E; Jung J; Jeong SY; Choi EK; Kim MB; Lee JS; Hong SM; Seol HS; Hwang C; Hoffman RM; Shim IK; Chang S; Kim SC
Anticancer Res; 2016 Feb; 36(2):517-21. PubMed ID: 26851005
[TBL] [Abstract][Full Text] [Related]
4. A rat-based preclinical platform facilitating transcatheter hepatic arterial infusion in immunodeficient rats with liver xenografts of patient-derived pancreatic ductal adenocarcinoma.
Ozaki M; Kageyama K; Kimura K; Eguchi S; Yamamoto A; Tanaka R; Nota T; Yonezawa H; Nishiofuku H; Sakai Y; Tani N; Jogo A; Terai M; Sato T; Ishizawa T; Miki Y
Sci Rep; 2024 May; 14(1):10529. PubMed ID: 38719893
[TBL] [Abstract][Full Text] [Related]
5. Optimal Organ for Patient-derived Xenograft Model in Pancreatic Cancer and Microenvironment that Contributes to Success.
Eguchi S; Kimura K; Kageyama K; Tani N; Tanaka R; Nishio K; Shinkawa H; Ohira GO; Amano R; Tanaka S; Yamamoto A; Takemura S; Yashiro M; Kubo S
Anticancer Res; 2022 May; 42(5):2395-2404. PubMed ID: 35489770
[TBL] [Abstract][Full Text] [Related]
6. Establishment of Patient-derived Orthotopic Xenografts (PDX) as Models for Pancreatic Ductal Adenocarcinoma.
Magouliotis DE; Lafazanis K; Koutsougianni F; Sakellaridis N; Ioannou M; Zacharoulis D; Dimas K
In Vivo; 2022; 36(3):1114-1119. PubMed ID: 35478141
[TBL] [Abstract][Full Text] [Related]
7. Genomic characterization of patient-derived xenograft models established from fine needle aspirate biopsies of a primary pancreatic ductal adenocarcinoma and from patient-matched metastatic sites.
Allaway RJ; Fischer DA; de Abreu FB; Gardner TB; Gordon SR; Barth RJ; Colacchio TA; Wood M; Kacsoh BZ; Bouley SJ; Cui J; Hamilton J; Choi JA; Lange JT; Peterson JD; Padmanabhan V; Tomlinson CR; Tsongalis GJ; Suriawinata AA; Greene CS; Sanchez Y; Smith KD
Oncotarget; 2016 Mar; 7(13):17087-102. PubMed ID: 26934555
[TBL] [Abstract][Full Text] [Related]
8. Generation and application of patient-derived xenograft models in pancreatic cancer research.
Wang CF; Shi XJ
Chin Med J (Engl); 2019 Nov; 132(22):2729-2736. PubMed ID: 31725451
[TBL] [Abstract][Full Text] [Related]
9. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis.
Kageyama K; Ohara M; Saito K; Ozaki S; Terai M; Mastrangelo MJ; Fortina P; Aplin AE; Sato T
J Transl Med; 2017 Jun; 15(1):145. PubMed ID: 28645290
[TBL] [Abstract][Full Text] [Related]
10. Local and Systemic Cytokine Profiling for Pancreatic Ductal Adenocarcinoma to Study Cancer Cachexia in an Era of Precision Medicine.
Gerber MH; Underwood PW; Judge SM; Delitto D; Delitto AE; Nosacka RL; DiVita BB; Thomas RM; Permuth JB; Hughes SJ; Wallet SM; Judge AR; Trevino JG
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513792
[TBL] [Abstract][Full Text] [Related]
11. Establishment and Characterisation by Expression Microarray of Patient-Derived Xenograft Panel of Human Pancreatic Adenocarcinoma Patients.
Roche S; O'Neill F; Murphy J; Swan N; Meiller J; Conlon NT; Geoghegan J; Conlon K; McDermott R; Rahman R; Toomey S; Straubinger NL; Straubinger RM; O'Connor R; McVey G; Moriarty M; Clynes M
Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32024004
[TBL] [Abstract][Full Text] [Related]
12. Metabolic difference between patient-derived xenograft model of pancreatic ductal adenocarcinoma and corresponding primary tumor.
Wen S; Lin X; Luo W; Pan Y; Liao F; Wang Z; Zhan B; Feng J; Huang H
BMC Cancer; 2024 Apr; 24(1):485. PubMed ID: 38632504
[TBL] [Abstract][Full Text] [Related]
13. Successful Secondary Engraftment of Pancreatic Ductal Adenocarcinoma and Cholangiocarcinoma Patient-Derived Xenografts After Previous Failed Primary Engraftment.
Hernandez MC; Yang L; Leiting JL; Sugihara T; Bergquist JR; Ivanics T; Graham R; Truty MJ
Transl Oncol; 2019 Jan; 12(1):69-75. PubMed ID: 30273859
[TBL] [Abstract][Full Text] [Related]
14. The canary in the coal mine: the growth of patient-derived tumorgrafts in mice predicts clinical recurrence after surgical resection of pancreatic ductal adenocarcinoma.
Thomas RM; Truty MJ; Kim M; Kang Y; Zhang R; Chatterjee D; Katz MH; Fleming JB
Ann Surg Oncol; 2015; 22(6):1884-92. PubMed ID: 25404477
[TBL] [Abstract][Full Text] [Related]
15. Oncological and genetic factors impacting PDX model construction with NSG mice in pancreatic cancer.
Guo S; Gao S; Liu R; Shen J; Shi X; Bai S; Wang H; Zheng K; Shao Z; Liang C; Peng S; Jin G
FASEB J; 2019 Jan; 33(1):873-884. PubMed ID: 30091943
[TBL] [Abstract][Full Text] [Related]
16. A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma.
Liu Z; Ahn MH; Kurokawa T; Ly A; Zhang G; Wang F; Yamada T; Sadagopan A; Cheng J; Ferrone CR; Liss AS; Honselmann KC; Wojtkiewicz GR; Ferrone S; Wang X
J Transl Med; 2020 Jun; 18(1):255. PubMed ID: 32580742
[TBL] [Abstract][Full Text] [Related]
17. Translational pancreatic cancer research: A comparative study on patient-derived xenograft models.
Rubio-Manzanares Dorado M; Marín Gómez LM; Aparicio Sánchez D; Pereira Arenas S; Praena-Fernández JM; Borrero Martín JJ; Farfán López F; Gómez Bravo MÁ; Muntané Relat J; Padillo Ruiz J
World J Gastroenterol; 2018 Feb; 24(7):794-809. PubMed ID: 29467550
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response.
Frappart PO; Walter K; Gout J; Beutel AK; Morawe M; Arnold F; Breunig M; Barth TF; Marienfeld R; Schulte L; Ettrich T; Hackert T; Svinarenko M; Rösler R; Wiese S; Wiese H; Perkhofer L; Müller M; Lechel A; Sainz B; Hermann PC; Seufferlein T; Kleger A
United European Gastroenterol J; 2020 Jun; 8(5):594-606. PubMed ID: 32213029
[TBL] [Abstract][Full Text] [Related]
19. A tunable delivery platform to provide local chemotherapy for pancreatic ductal adenocarcinoma.
Indolfi L; Ligorio M; Ting DT; Xega K; Tzafriri AR; Bersani F; Aceto N; Thapar V; Fuchs BC; Deshpande V; Baker AB; Ferrone CR; Haber DA; Langer R; Clark JW; Edelman ER
Biomaterials; 2016 Jul; 93():71-82. PubMed ID: 27082874
[TBL] [Abstract][Full Text] [Related]
20. Patient-Derived Xenografts Can Be Reliably Generated from Patient Clinical Biopsy Specimens.
Hernandez MC; Bergquist JR; Leiting JL; Ivanics T; Yang L; Smoot RL; Nagorney DM; Truty MJ
J Gastrointest Surg; 2019 Apr; 23(4):818-824. PubMed ID: 30756315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]